WO2023215239A1 - Systèmes et procédés de réalisation d'une chirurgie en utilisant la rétractation de tension de la loi de laplace pendant la chirurgie - Google Patents

Systèmes et procédés de réalisation d'une chirurgie en utilisant la rétractation de tension de la loi de laplace pendant la chirurgie Download PDF

Info

Publication number
WO2023215239A1
WO2023215239A1 PCT/US2023/020596 US2023020596W WO2023215239A1 WO 2023215239 A1 WO2023215239 A1 WO 2023215239A1 US 2023020596 W US2023020596 W US 2023020596W WO 2023215239 A1 WO2023215239 A1 WO 2023215239A1
Authority
WO
WIPO (PCT)
Prior art keywords
stomach
medical device
pressure
balloon
inflation
Prior art date
Application number
PCT/US2023/020596
Other languages
English (en)
Inventor
Jonathan R. Thompson
Mark Steven Ortiz
Saylan James LUKAS
Liam Clayton GROOM
Original Assignee
Standard Bariatrics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/738,916 external-priority patent/US20220257400A1/en
Application filed by Standard Bariatrics, Inc. filed Critical Standard Bariatrics, Inc.
Publication of WO2023215239A1 publication Critical patent/WO2023215239A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/0083—Reducing the size of the stomach, e.g. gastroplasty
    • A61F5/0086—Reducing the size of the stomach, e.g. gastroplasty using clamps, folding means or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/0073—Implantable devices or invasive measures in the abdominal cavity, e.g. not attached to the stomach
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/02—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors
    • A61B17/0218—Surgical instruments, devices or methods, e.g. tourniquets for holding wounds open; Tractors for minimally invasive surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
    • A61B17/072—Surgical staplers, e.g. containing multiple staples or clamps for applying a row of staples in a single action, e.g. the staples being applied simultaneously
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/122—Clamps or clips, e.g. for the umbilical cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/128—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord for applying or removing clamps or clips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017—Electrical control of surgical instruments
    • A61B2017/00022—Sensing or detecting at the treatment site
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017—Electrical control of surgical instruments
    • A61B2017/00115—Electrical control of surgical instruments with audible or visual output
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017—Electrical control of surgical instruments
    • A61B2017/00115—Electrical control of surgical instruments with audible or visual output
    • A61B2017/00119—Electrical control of surgical instruments with audible or visual output alarm; indicating an abnormal situation
    • A61B2017/00123—Electrical control of surgical instruments with audible or visual output alarm; indicating an abnormal situation and automatic shutdown
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00535—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
    • A61B2017/00557—Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated inflatable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00818—Treatment of the gastro-intestinal system
    • A61B2017/00827—Treatment of gastro-esophageal reflux
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/30—Surgical pincettes without pivotal connections
    • A61B2017/306—Surgical pincettes without pivotal connections holding by means of suction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/06—Measuring instruments not otherwise provided for
    • A61B2090/064—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2217/00—General characteristics of surgical instruments
    • A61B2217/002—Auxiliary appliance
    • A61B2217/005—Auxiliary appliance with suction drainage system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
    • A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
    • A61F5/0013—Implantable devices or invasive measures
    • A61F5/005—Gastric bands

Definitions

  • the examples herein may be directed to a sleeve gastrectomy, and more particularly to a bougie or medical tube inserted into the stomach and used in conjunction with a sleeve gastrectomy stapler or clamp.
  • the example devices herein may provide proper tension of the stomach tissue during clamping of the stapler or clamp during the creation of a vertical sleeve gastrectomy.
  • Obesity is a disease that affects a significant portion of the world's population and leads to multiple chronic medical conditions and premature death from cardiovascular events and cancer.
  • the United States has a current, and worsening obesity epidemic.
  • the U.S. Centers for Disease Control and Prevention (CDC) reports that over 33% of the U.S. population is obese, with a Body Mass Index (BMI) of over 30, and another 35-40% of the US population is overweight, with a BMI of 25-30.
  • BMI Body Mass Index
  • the CDC reports that the percent of the US population being either overweight or obese by 2018 will be 75%.
  • the CDC also reports that obesity directly costs the U.S. economy $147 billion currently, and projects that the costs will approach $315 billion by 2020.
  • bariatric surgery may be an option for some patients that may be overweight.
  • bariatric surgery may be an effective long-term treatment option for patients with a BMI greater than 35.
  • Laparoscopic vertical sleeve gastrectomy may be a procedure that may be safer and more effective for patients eligible for weight loss surgery.
  • it has been accepted as the surgery that should be offered to most morbidly obese patients over, for example, laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass.
  • the surgery has been adopted by bariatric surgeons and is now the most commonly performed weight loss surgery.
  • Vertical sleeve gastrectomy is typically performed using standard laparoscopic equipment.
  • the greater curvature of the stomach is mobilized using vessel-sealing devices, sealing the gastric branches of the gastroepiploic vessels and the short gastric vessels.
  • the posterior adhesions of the stomach are also divided so the stomach is fully mobilized while the blood supply to the lesser curvature remains intact.
  • a calibration tube is typically introduced into the stomach through the mouth.
  • Resection is accomplished by applying a series of staples from a laparoscopic linear surgical stapler, for example, along the calibration tube in a staple line.
  • the staple line may be important in sleeve gastrectomy as the amount of weight lost and complications or consequences may be a direct result of the quality of the resultant sleeve gastrectomy pouch formed from the staple line (e.g., the portion of the stomach not rescinded by the staple line).
  • the complications or consequences may include gastroesophageal reflux disorder (GERD), weight loss failure or weight regain, food intolerance, staple line bleed, leak, and/or the like.
  • GERD gastroesophageal reflux disorder
  • the stomach resection line is long (e.g., up to 22cm). While the stomach is being stapled, sections of the stomach are retracted. Each section may be, for example, 3cm in length and requires incorporation of equal amounts of the anterior and posterior sides of the stomach.
  • Stomach tissue can be modelled as a series of ropes or elastic fibers. These must be pulled in the correct traction force vector relative to the clamp or stapler with 4 dimensions or axes of direction (i.e. , up/down oranterior/posterior; left/right; caudad/cephalad; and rotation) and 1 dimension of magnitude. Maintaining proper tension during each clamp or staple is important to produce a sleeve gastrectomy pouch (e.g., from the staple line) without negatively affecting or interfering with the natural elasticity of the tissue.
  • a sleeve gastrectomy shaping tube may be used. Unfortunately, the surgeon must still manually manipulate the stomach to apply tension while planning the resection line using existing methods.
  • an apparatus for performing a sleeve gastrectomy can include a bougie for insertion into an interior of a stomach, the bougie having a proximal bougie end and a distal bougie end, an inflation lumen having a proximal lumen end and a distal lumen end, the inflation lumen extending from the proximal bougie end through the distal bougie end, a fluid delivery system coupled with the proximal lumen end, the fluid delivery system being operably configured to deliver positive pressure in a predetermined positive pressure range into the stomach, and a monitor coupled with the proximal lumen end operably configured for the monitoring of pressure or volume within the stomach.
  • the bougie can be operably configured to define a resection line for a sleeve gastrectomy when the predetermined positive pressure range is achieved within the stomach.
  • the bougie can include at least one balloon portion positioned at the distal bougie end.
  • the inflation lumen can be used for both inflation and suction.
  • the fluid delivery system can be a hand pump or a foot pump.
  • the monitor can be a visual indicator or an audible indicator.
  • the monitor can include a control system for metering a fluid delivered through the inflation lumen.
  • the bougie can include at least one sensor coupled with the distal bougie end for monitoring a pressure or volume within the stomach.
  • the distal bougie end can include a shaping portion that can be a balloon or an articulating tip.
  • the distal bougie end can include an overtube.
  • the inflation lumen can be a multilumen catheter.
  • the predetermined positive pressure range can be from 15mmHG to 20mmHG.
  • an apparatus for performing a sleeve gastrectomy can include a bougie for insertion into an interior of a stomach, the bougie having a proximal bougie end and a distal bougie end, an inflation lumen having a proximal lumen end and a distal lumen end, the inflation lumen extending from the proximal bougie end through the distal bougie end, a fluid delivery system coupled with the proximal lumen end, the fluid delivery system being operably configured to deliver a predetermined range of positive pressure into the stomach, and a control system coupled with the proximal lumen end for the metering and monitoring of pressure or volume within the stomach.
  • the bougie can be operably configured to cooperate with a stapler or clamp to define a resection line for a sleeve gastrectomy when the predetermined positive pressure range is achieved within the stomach.
  • Embodiments of a system for performing a sleeve gastrectomy can include a first medical device, the first medical device having a bougie for insertion into an interior of a stomach, the bougie having a proximal bougie end and a distal bougie end, an inflation lumen having a proximal lumen end and a distal lumen end, the inflation lumen extending from the proximal bougie end through the distal bougie end, a pump coupled with the proximal lumen end, the pump being operably configured to deliver a predetermined positive pressure range into the stomach, a monitor coupled with the proximal lumen end for the monitoring of pressure or volume of the stomach, and a shaping portion, the shaping portion being positioned at the distal bougie end, wherein the shaping portion is operably configured to position a portion of the stomach.
  • the system can include a second medical device, the second medical device being a stapler or clamp positioned externally on the stomach laterally adjacent to the first medical device.
  • the first medical device and the second medical device can be operably configured to define a resection line for a sleeve gastrectomy when the predetermined positive pressure range is achieved within the stomach and the second medical device can be operably configured to clamp the stomach along the resection line.
  • Example methods for performing a sleeve gastrectomy can include the steps of providing a first medical device including a tube for insertion into an interior of a stomach, the tube having a proximal end and a distal end, the distal end comprising a shaping portion; providing an inflation lumen for the introduction of positive pressure into the stomach; providing a second medical device, the second medical device being a stapler or clamp positioned externally on the stomach laterally adjacent to the first medical device; introducing positive pressure into the stomach via the inflation lumen; defining a resection line for a sleeve gastrectomy, wherein the resection line is defined at least partially by the position of the second medical device relative to the first medical device when a predetermined positive pressure range is provided via the inflation lumen; and clamping the stomach using the second medical device along the resection line.
  • Methods can include a bougie including the inflation lumen.
  • the first medical device can comprise a bougie having a first balloon portion, the first balloon portion having a first balloon inflation lumen.
  • the first balloon portion can be a non-compliant balloon having a predetermined shape in an inflated configuration.
  • Methods can include an indicator associated with the predetermined positive pressure range of the stomach being achieved.
  • the indicator can be a visual or audible indicator signaling that a positive pressure within the stomach is below the predetermined positive pressure range, above the predetermined positive pressure range, or within the predetermined positive pressure range.
  • the predetermined positive pressure range can be from 1 mmHG to 25mmHG.
  • the predetermined positive pressure range can be from 15mmHg to 20mmHg.
  • the method can include providing a release for when a pressure within the stomach is greater than the predetermined positive pressure range.
  • the first medical device can include a suction portion and an inflation portion, where the suction portion is operably configured to urge a first portion of the stomach proximate the suction portion and the inflation portion is operably configured to inflate the stomach to the predetermined positive pressure range.
  • the suction portion can be positioned proximate the GE junction of the stomach.
  • the suction portion can be positioned proximate the antrum of the stomach.
  • the suction portion of the first medical device can extend from a portion proximate the GE junction of the stomach to a portion proximate the antrum of the stomach.
  • the inflation lumen can be selectively configured to provide suction.
  • the distal end of the first medical device can include an articulating member, the articulating member being operably configured to position the antrum relative to the second medical device.
  • Example methods where defining a resection line comprises applying a first amount of compression to the stomach with the second medical device when the positive pressure is introduced into the stomach, and applying a second amount of compression to the stomach when pressure within the stomach has reached the predetermined positive pressure range, wherein the second amount of compression is greater than the first amount of compression and the second amount of compression is operably configured to immovably retain the stomach.
  • Example methods where the step of clamping includes providing a first clamping force with the second medical device prior to the resection line being defined, and a second clamping force with the second medical device after the resection line is defined to immovably secure the stomach therein.
  • Example methods where the step of clamping includes first clamping a lower portion of the stomach, defining the resection line, and clamping the full length of the stomach using the second medical device.
  • Example methods where the step of clamping the stomach with the second medical device comprises stapling the stomach and resecting a portion of the stomach.
  • the first medical device can comprise a plurality of balloon portions.
  • the distal end of the first medical device can be operably configured to articulate.
  • the first medical device can include at least one sensor to measure the pressure or volume within the stomach.
  • the first medical device or the second medical device include a sensor to measure tension, pressure, or volume of the stomach.
  • Example methods in accordance with embodiments described herein can include the steps of providing a first medical device including a tube for insertion into an interior of a stomach, the tube having a proximal end, a distal end, and at least one balloon portion, the distal end comprising a shaping portion; providing an inflation lumen for the introduction of positive pressure into the stomach, wherein the inflation lumen is coupled with a pump, a pressure gauge, and a pressure release valve; providing a second medical device, the second medical device being a stapler or clamp positioned externally on the stomach laterally adjacent to the first medical device; introducing positive pressure into the stomach via the inflation lumen until a predetermined range of pressure is achieved; defining a resection line for a sleeve gastrectomy, wherein the resection line is defined at least partially by the position of the second medical device relative to the first medical device when the predetermined positive pressure range is achieved; clamping the stomach using the second medical device along the resection line; stapling the stomach using the second
  • Example methods can include a bougie, the bougie including the inflation lumen.
  • the first medical device can comprise a bougie having at least one balloon portion, the at least one balloon portion having at least one balloon inflation lumen.
  • Example methods can include an indicator for determining when the predetermined positive pressure range of the stomach has being achieved.
  • the indicator can be a visual or audible indicator signaling that a positive pressure within the stomach is below the predetermined threshold range, above the predetermined threshold range, or within the predetermined threshold range.
  • the predetermined positive pressure range can be from 1 mmHG to 25mm HG.
  • the predetermined positive pressure range can be from 15mmHg to 20mmHg.
  • the first medical device can include a suction portion and an inflation portion, where the suction portion is operably configured to urge a first portion of the stomach proximate the suction portion and the inflation portion is operably configured to inflate the stomach to the predetermined positive pressure range.
  • the suction portion can be positioned proximate the GE junction of the stomach, proximate the antrum of the stomach, or can extend from a portion proximate the GE junction of the stomach to a portion proximate the antrum of the stomach.
  • the inflation lumen can be selectively configured to provide suction.
  • the distal end of the first medical device can include an articulating member, the articulating member being operably configured to position the antrum relative to the second medical device.
  • the first medical device can include at least one sensor to measure pressure or volume within the stomach.
  • FIG. 1 depicts a perspective view of a system according to an embodiment, the system including a first medical device and a second medical device positioned relative to a stomach.
  • FIG. 2A depicts a perspective view of the first medical device of the system of FIG. 1.
  • FIG. 2B depicts an elevation view of the first medical device of the system of FIG. 1.
  • FIG. 2C depicts a cross-sectional view of the first medical device of FIG. 2A taken along section 2C— 2C.
  • FIG. 3 is a flow chart depicting a fluid delivery system according to an embodiment.
  • FIG. 4A is a flow chart depicting a fluid delivery system according to another embodiment.
  • FIG. 4B is a flow chart depicting a fluid delivery system according to another embodiment.
  • FIG. 4C depicts a perspective view of a hand pump according to an embodiment.
  • FIG. 5A depicts a perspective view of the system of FIG. 1 where the first medical device is positioned in the stomach lumen and the second medical device is positioned outside the stomach adjacent to the first medical device in an example method of creating a resection path during a sleeve gastrectomy.
  • FIG. 5B depicts a perspective view of the system of FIG. 1 where the shaping portion of the first medical device is inflated and the stomach lumen is being pressurized.
  • FIG. 5C depicts a perspective view of the system of FIG. 1 where the pressure in the stomach has increased to urge the second medical device against the first medical device.
  • FIG. 5D depicts a perspective view of the system of FIG. 1 where the second medical device has been clamped.
  • FIG. 5E depicts a perspective view of the system of FIG. 1 where the shaping portion of the first medical device and the stomach lumen have been deflated.
  • FIG. 5F is a flow chart depicting a set of steps that may be performed with the system during the procedure illustrated by FIGS. 5A through 5E.
  • FIG. 6A depicts an elevation view of a distal portion of a first medical device capable of applying suction according to an embodiment.
  • FIG. 6B depicts an elevation view of a distal portion of a first medical device capable of applying suction according to another embodiment.
  • FIG. 6C depicts an elevation view of a distal portion of a first medical device capable of applying suction according to another embodiment.
  • FIG. 7 depicts a perspective view of a first medical device including an overtube in accordance with an embodiment.
  • FIG. 8A depicts a cross-sectional view of a first medical device including a gastroscope in according to an embodiment.
  • FIG. 8B depicts a cross-sectional view of a first medical device including a gastroscope in accordance with another embodiment.
  • FIG. 9 depicts a perspective view of a system according to an embodiment, the system including a first medical device and a second medical device positioned relative to a stomach, and a connector attached to two sections of the stomach tissue.
  • FIG. 10 depicts a perspective view of a first medical device including an articulating tip in accordance with an embodiment.
  • FIG. 11 A depicts a perspective view of a first medical device including a tissue anchor in accordance with an embodiment.
  • FIG. 11 B depicts a perspective view of the first medical device of FIG. 11 B and a stylet used to straighten the first medical device after tissue has been anchored to the tissue anchor.
  • FIG. 12A depicts an elevation view of a first medical device including a perforated sheath in accordance with an embodiment.
  • FIG. 12B depicts an elevation view of the first medical device of FIG. 12A with the shaping portion in an expanded state.
  • FIG. 12C depicts a cross-sectional view of the first medical device of FIG. 12A with the shaping portion in an expanded state.
  • FIG. 13 depicts a perspective view of a first medical device including an inflatable balloon extending through the pyloric sphincter in accordance with an embodiment.
  • FIG. 14A depicts a perspective view of the system of FIG. 1 including an inflatable balloon inserted into the stomach lumen on the remnant side.
  • FIG. 14B depicts a perspective view of the system of FIG. 14A after the balloon has been inflated.
  • FIG. 15 depicts a perspective view of a first medical device including a segmented shaping portion in accordance with an embodiment.
  • FIG. 16A depicts a cross-sectional view of a first medical device including suction zones in accordance with an embodiment, where the second medical device is in a first position.
  • FIG. 16B depicts a cross-sectional view of the first medical device of FIG. 16A, where the second medical device is in a second position.
  • FIG. 16C depicts a cross-sectional view of the first medical device of FIG. 16A, where the second medical device is in a third position.
  • FIG. 17A depicts a perspective view of a tube portion of a first medical device including suction zones in accordance with an embodiment.
  • FIG. 17B depicts a perspective view of the tube portion of FIG. 17A with the cap removed.
  • FIG. 18A depicts a perspective view of a first medical device including suction zones in accordance with an embodiment.
  • FIG. 18B depicts a perspective view of a shaping portion of the first medical device of FIG. 18A.
  • FIG. 18C depicts a perspective view of the shaping portion and the tube portion of the first medical device of FIG. 18A.
  • FIG. 18D depicts a perspective view of a manifold cap of the first medical device of FIG. 18A.
  • FIG. 19A depicts a cross-sectional view of a first medical device including suction zones in accordance with another embodiment.
  • FIG. 19B depicts a cross-sectional view of a first medical device of FIG. 19A with the shaping portion inflated.
  • FIG. 20A depicts a top-down view of a controller for a fluid delivery system.
  • FIG. 20B depicts a perspective view of the controller of FIG. 20A.
  • FIG. 20C is a flow chart depicting a set of steps that may be performed with a fluid delivery system that includes the controller of FIG. 20A.
  • FIG. 21 A is a diagram illustrating a control interface for a fluid delivery system.
  • FIG. 21 B is a diagram illustrating an alternate control interface for a fluid delivery system.
  • FIG. 21 C is a diagram illustrating yet another alternate control interface for a fluid deliver system.
  • systems and/or methods may be provided for performing a sleeve gastrectomy without disturbing the natural tension lines of the stomach tissue. Additionally, the systems and/or methods described herein may allow for proper sizing of the resulting sleeve gastrectomy pouch.
  • some embodiments include a system 10 including a first medical device 100, such as a bougie, and a second medical device 300, such as a clamp or stapler. According to an example herein, the first and second medical devices 100, 300 may be used to perform a vertical sleeve gastrectomy.
  • the sleeve gastrectomy (e.g., resection of part of the stomach) may be performed along a path, such as a resection line, to produce a resultant sleeve gastrectomy pouch ("sleeve") of the stomach 12.
  • a first medical device 100 may be positioned in an interior of the stomach 12.
  • the first medical device 100 may include or have a first diameter along a first portion thereof (e.g., a bougie or tube, such as an orogastric tube) and a second diameter that may be larger than the first diameter along a second portion thereof (e.g., a shaping portion, an inflated portion, or a radially-outward projecting portion).
  • the first medical device 100 may be positioned, for example, by inserting the first medical device into a mouth of a patient to access the interior of the stomach 12 and positioning the second portion at a landmark of the stomach 12, as discussed further below.
  • the second medical device 300 may be positioned on an exterior of the stomach 12 relative to or based on an interaction with the first medical device 100 (e.g., adjacent to, near, in proximity to, and/or interaction with the second portion of the first medical device) such that the second medical device 300 may be configured to demonstrate or create a path such as a resection line or staple line) along the stomach 12 at which the sleeve gastrectomy may be performed.
  • the tension may be uniform in the anterior/posterior plane (e.g., across a transverse cross-section of the stomach), although the tension would vary along the length of the stomach as the radius varies.
  • the Law of Laplace governs how a balloon inflates.
  • the second medical device 300 may be clamped partially or wholly while the stomach 12 is inflated.
  • the second medical device 300 may be a clamp, such as a full length 23cm clamp configured to extend the full length of the stomach.
  • the second medical device 300 may include a first jaw 302 or first clamp member and a second jaw 304 or second clamp member.
  • the anatomical structure has a first side and a second side.
  • the first jaw 302 may have a first end, a second end and a cartridge housing a plurality of staples, the cartridge having a cartridge face that may be positionable on the first side of the stomach, and the second jaw 304 may have a first end, a second end, and an anvil having an anvil face that may be positionable on the second side of the stomach.
  • the second medical device may include an end effector (e.g., including the jaws 302, 304) having a distal end 306 and a proximal end 308. Examples of suitable second medical devices are disclosed in U.S. Patent Nos. 9,936,953, 10,278,707, and 10,548,597, each of which is hereby incorporated herein by reference in its entirety.
  • the first medical device 100 may be a shaping bougie, catheter, or tube, such as an orogastric tube.
  • the first medical device 100 includes a tube portion 102 and a shaping portion 104.
  • the tube portion 102 may be generally cylindrical in shape and may be made of, for example, rubber, silicone, polyurethane, a plastic polymer, and/or any other suitable material.
  • the diameter of the tube portion 102 is constant. In another embodiment, the diameter of the tube portion 102 varies.
  • the tube portion 102 may be hollow, solid, define multiple internal lumen and/or the like in one or more examples.
  • the tube portion 102 may comprise a body 105 including a proximal end 106 that may be closer to a surgeon or other user to a distal end 108 that may be farther away from the surgeon.
  • a section of the tube portion 102, ending at the distal end 108, or the distal bougie end, may be long enough to allow for easy insertion into the mouth, esophagus, and stomach, and/or may enable or allow the distal end 108 to be navigated down towards the pylorus 14 of the stomach.
  • the first medical device 100 may include an intragastric section 110 that, when in use, is positioned in the stomach 12 adjacent the lesser curvature 16.
  • the intragastric section 110 may include a proximal end 112 (i.e., distal of the proximal end 106 of the tube portion 102).
  • the location of the proximal end 1 12 may not be fixed along the length of the tube portion 102.
  • the distal end 108 of the tube portion 102 may also be the distal end of the intragastric section 110.
  • the first medical device 100 may include lights or other visualization features to improve the use of the first medical device 100 as a guide (e.g., to aid with visualization through the stomach wall).
  • the size of the tube portion may be, in various examples, in a range of 16 French (Fr) to 40 Fr, 16 Fr to 20 Fr, or 32 Fr to 40 Fr. Examples of a suitable tube portion 102 is a 18 Fr bougie, a 34 Fr bougie, or a 38 Fr bougie.
  • the shaping portion 104 may comprise, for example, one or more inflatable balloons 114 or collapsible portions.
  • the shaping portion 104 may be adjustable between a first state having a first average diameter and a second state having a second average diameter.
  • the balloon may be interchangeable with a collapsible portion that may have an expanded or retracted state.
  • the balloon 114 may be relaxed or deflated prior to use and insertion of the first medical device 100 in the stomach.
  • the tube portion 102 and the balloon 114 in the relaxed or deflated state may have a substantially constant diameter.
  • the balloon 114 may be inflated to an inflated state after insertion of the first medical device 100 into the stomach to the appropriate position.
  • a proximal end 116 of the shaping portion 104 may be positioned adjacent to the GE junction 18 or the incisura angularis (IA) 20.
  • the distal end 118 of the shaping portion 104 may be, for example, positioned adjacent to the antrum 22.
  • the balloon 114 in the inflated state may have the second average diameter.
  • the diameter of the shaping portion 104 may vary along the length.
  • the inflated diameter at the distal end 118 of the shaping portion 104 may be greater than the diameter at the proximal end 1 16.
  • the size of the inflated or expanded shaping portion 104 may, in an embodiment, be determined based on the desired size of the resulting sleeve.
  • An example of a suitable shaping portion 104 is a balloon with a maximum diameter of 2.5cm. In another example, the maximum diameter of the shaping portion 104 may be about 3.2cm.
  • the area of the shaping portion 104 configured to have the maximum diameter may be located adjacent the distal end 108 of the tube portion 102.
  • the area of the shaping portion 104 configured to have the maximum diameter may be located about 20mm or less from the distal end 108 of the tube portion 102.
  • the minimum diameter of the shaping portion may be, in an embodiment, about the diameter of the tube portion 102 (e.g., slightly larger than the tube portion 102 diameter to allow the shaping portion 104 to extend around the tube portion 102).
  • the tube portion 102 is a 34 Fr catheter
  • the shaping portion 104 includes a tapered balloon 114 having a minimum diameter at the proximal end 116 of slightly greater than the diameter of the 34 Fr catheter, which increases along a length of 21cm to the distal end 118 where the maximum diameter is 3.2cm.
  • the length of the shaping portion 104 may vary. In an embodiment, the length of the shaping portion 104 may be in a range of about 4cm to about 21 cm, 15cm to 20cm, or about 21cm.
  • the shaping portion 104 in combination with positive pressure in the stomach lumen, may enable the stomach tissue to have a proper and uniform tension applied to the stomach wall when the second medical device 300 is clamped to the stomach.
  • the tension may be uniform or symmetric around a diameter (e.g. , a transverse cross-section) of the resultant sleeve.
  • the first medical device 100 may be placed with the balloon 114 adjacent the incisura angularis 20 in the deflated state.
  • the second medical device 300 may then be placed in apposition but not fully clamped, the balloon 114, which may be compliant or non-compliant, may be inflated to the inflated state.
  • the stomach lumen is also inflated, as described further below, which creates uniform tension in the stomach tissue of the intended sleeve prior to clamping.
  • the desired tension is reached, at a pressure of 20mm HG for example, the second medical device 300 is clamped.
  • the balloon 114 may be deflated such that the first medical device 100 may be removed before or after stapling.
  • the cross- sectional area of the IA 20 in the resulting sleeve may be maintained or increased in comparison with a sleeve formed by prior methods that may cause a narrowing in the cross-sectional area of the IA 20.
  • the shaping portion 104 may be integrally formed as a unitary monolithic structure as part of the tube portion 102, for example, during manufacturing. In additional or alternative examples, the shaping portion 104 may be separately coupled and/or fixedly attached to the tube portion 102 and/or may include multiple separate pieces.
  • the shaping portion 104 may be unitary or may be segmented. In various embodiments, the one or more balloons 114 can be compliant, semi-compliant, noncompliant, or combinations thereof. If the shaping portion 104 is segmented, each segment may vary in shape and size.
  • the shaping portion 104 may be placed relative to one or more desired anatomic landmarks.
  • the desired landmark may vary based on the type of first medical device or application. Examples of desired landmarks include the incisura angularis 20, the pylorus 14, and the gastroesophageal (GE) junction 18.
  • the shape of the shaping portion 104 may vary based on the desired landmark.
  • the shaping portion 104 may be a cylinder positioned at the incisura angularis 20, a frustrum positioned at the pylorus 14, or a long cone or teardrop shape that can be considered a sleeve mold, although the shapes are not so limited.
  • the system may include one or more fluid circuits, such as a fluid delivery system, to provide positive pressure to the shaping portion and/or the stomach lumen.
  • a fluid delivery system such as a foot pump or hand pump.
  • the tube portion 102 may define a lumen 120 extending between a distal aperture 122 or distal lumen end and a proximal aperture 124 or proximal lumen end.
  • the distal aperture 122 may open into the stomach lumen
  • the proximal aperture 124 may be coupled to a fluid source (e.g., via a connecting tube 126).
  • the tube portion 102 may also define a lumen 128 fluidically coupling the interior of the balloon 114 (e.g., via an aperture 130) and a fluid source (e.g., via a coupling 132).
  • the fluid may be a gas (e.g., ambient air, central air, CO2, or nitrogen) or a liquid (e.g., an aqueous solution, such as saline, or water).
  • the tube portion 102 and the shaping portion 104 are coupled to separate fluid sources, the fluid sources may be the same or different.
  • components other than the first medical device 100 may be coupled to a fluid circuit.
  • the one or more fluid circuits or fluid delivery systems may be coupled to a pump system.
  • the tube portion 102, the shaping portion 104, and/or a separate catheter in communication with the stomach lumen can be coupled with a pneumatic pump to provide positive pressure and/or suction.
  • a system including a multi-lumen catheter e.g., the tube portion 102 is coupled to an inflation pump 134 and a suction pump 136 through a three- way valve 138.
  • the pumps 134, 136 may be controllable by mechanical means, such as an inflation foot pedal 139 and a suction foot pedal 140.
  • the pump may also be configured to control suction.
  • Suitable pumps include, without limitation, a foot pump, a hand pump, an electric motor pump, or a combination thereof.
  • a mechanical foot pump may include, for example, a bellows and one or more pedals.
  • a hand pump may include a stopcock that may be turned after clamping.
  • a motorized pump may include switches or pedals for positive pressure or suction.
  • the pump system may include a pump configured to apply both inflation and suction.
  • a system including a multi-lumen catheter e.g., the tube portion 102
  • the three-way valve 138 may be a part of the pump 142 or a separate component.
  • the pump 142 may be controllable by mechanical means, such as a foot pedal 144. Although one pedal 144 is shown and may be configured to control both suction and inflation, more than one may be included.
  • FIG. 4B illustrates an embodiment including a first and second fluid delivery system.
  • the first fluid delivery system is coupled to the tube portion (e.g., lumen 120) including a sensor 160, a hand pump 134 (see FIG. 4C), and a sensor 160.
  • the second fluid delivery system includes an inflation/suction pump 142 and a sensor 160 coupled to the balloon 114 of the shaping portion.
  • FIG. 4C depicts an example hand pump 134 including a bulb 134a coupled to a 2-way stopcock 134b via tubing 134c.
  • the 2-way stopcock 134b is also coupled to an adapter 134d to be connected to a suction source and an adapter 134e to be coupled to the first medical device 100.
  • the hand pump 134 may also include a pressure gauge 134f.
  • Alternative to pedals, in an embodiment, buttons may be incorporated into the second medical device 300 to inflate and deflate the stomach, as discussed further below.
  • the pump 142 can be associated with a monitor or control system for the monitoring and metering of the fluid to be delivered such that the stomach is not overinflated.
  • the monitor can include a visual or audible indicator of when the stomach pressure or stomach volume if, for example, above a desirable predetermined range, below a predetermined range, or within the predetermined range.
  • the monitor or control system can include a release valve set at a pressure above the desirable predetermined range to offgas fluid to return the stomach volume or pressure to an acceptable range.
  • the control system may include any suitable features to provide a constant volume or pressure within the stomach, which may differ from prior techniques that insufflate the stomach to test for leaks and the like.
  • Prior insufflation testing methods may use relatively high pressures, such as above 25mm Hg, to test for leaks without the need to meter or maintain such a pressure within a defined range.
  • pressures in insufflation test applications which can exceed 50mmHg to 75mmHg may be too high for use with the presently described systems.
  • Embodiments described herein can include suitable feedback sensors and the like with the first medical device or bougie to allow the control system to adjust pressure or volume in accordance with embodiments described herein.
  • the first medical device may be configured to maintain a higher pressure in the shaping portion 104 than the stomach lumen during the sleeve gastrectomy procedure.
  • the maximum pressure of the shaping portion 104 may be in a range of, for example, 40mmHg to 70mmHg.
  • the maximum pressure of the stomach lumen may be, for example, up to 20mmHg (the physiologic ‘pain’ pressure of the stomach), in a range of about 20mmHg to about lOOmmHg, or up to l OOmmHg. If the surgery is being performed laparoscopically, the pneumoperitoneum will need to be accounted for (e.g., lOmmHg to 20mmHg). This pressure allows the stomach to inflate but not be unnaturally deformed. Further, the tension provided by the pressure has a direction and magnitude natural to the stomach tissue.
  • the tension relieves the surgeon from the necessity of manipulating the tissue and potentially disrupting the natural tension pattern of the stomach tissue, although the surgeon may still manipulate the tissue manually if desired.
  • the direction of the tension vector is generally at a right angle to the longitudinal axis of the second medical device 300 (e.g. , longitudinal axis of the jaws 302, 304), which may provide a better resection line.
  • the pressure used to inflate the shaping portion 104 may vary. In an example, the pressure used to inflate a balloon with water may be about 1 15mmHg.
  • FIGS. 5A-5E an example method or procedure that may be performed using the first medical device 100 and second medical device 300 is shown.
  • the first medical device 100 is inserted in a stomach 12.
  • the first medical device 100 is placed along the lesser curvature 16 adjacent to one or more desired anatomic landmarks.
  • a second medical device 300 such as a full-length 23cm clamp or stapler, is placed across the length of the stomach (FIG. 5A).
  • the lumen 120 is connected to positive pressure. The positive pressure may be applied to begin inflating the stomach (FIG. 5B).
  • the first medical device 100 may also include a shaping portion 104 that is inflated using positive pressure. Methods of controlling and monitoring the positive pressure are described above.
  • the balloon-like stomach urges the second medical device 300 to become adjacent and snug against the shaping portion 104 of the first medical device 100.
  • the stomach inflates FIG. 5C
  • the growing pressure in the larger portion of the stomach causes the second medical device 300 to move towards the first medical device 100 and pushes the tissue between the first and second medical devices 100, 300 against the shaping portion 104, while uniform tension is applied to the stomach wall.
  • the tissue along the lesser curvature 16 of the stomach may also be drawn towards the shaping portion 104.
  • the pressure may be reduced manually or automatically to allow proper sizing of the desired sleeve before clamping. If desired, the surgeon may manipulate the tissue during inflation to control the shape and size of the resulting sleeve.
  • the second medical device 300 may then be partially or fully clamped (FIG. 5D).
  • the stomach lumen may be suctioned (FIG. 5E) before or after fully clamping the second medical device 300.
  • the first medical device 100 may be removed from the stomach after clamping but before stapling. If the stomach is suctioned, positive pressure may be reintroduced to perform a leak test.
  • the stomach may be stapled and cut (i.e., resected) along the resection line defined by the second medical device 300.
  • Embodiments herein may allow for stapling and cutting along a straight resection line while the resulting sleeve is curved along the staple line.
  • the second medical device 300 is a full-length stapler, the disclosure is not so limited.
  • the second medical device is a less- than-f ull-length stapler.
  • the first activation of the stapler may be done before or after the positive pressure is applied to the stomach lumen.
  • the stapler may then be advanced across the length of the stomach while the stomach is inflated.
  • the first medical device 100 acts as a guide to the surgeon.
  • Laplace retraction allows for each Tope’ or ‘elastic band’ of the stomach to be pulled in the correct direction as the positive pressure provides tension along the natural stomach distension vectors, preventing the surgeon from having to manually manipulate the stomach (e.g., using a laparoscopic grasper) in an attempt to create the desired tension.
  • the pressure also pulls every gastric fiber simultaneously, not relying on the segments of tissue that a laparoscopic grasper can grab at one time.
  • the positive pressure can flatten out all parts of the stomach, preventing the clam ping/stapli ng of folded stomach. Stapling folded stomach tissue can lead to staple line failure and leak.
  • the resultant sleeve may have, for example, a diameter of 1 to 3 cm near a first landmark (e.g., the I A), 2 to 6 cm near a second landmark (e.g., the size of the antrum measured from the pylorus), and 0 to 2 cm near a third landmark (e.g., measured from the edge of the GE junction notch) of the stomach.
  • the resultant sleeve may have a diameter of 1 cm to 2cm at the fundus, a diameter of 2cm to 3 cm at the body at the incisura angularis, and a diameter of 3cm to 6cm at the antrum.
  • FIG. 5F depicts a set of steps that may be performed with the system during the procedure illustrated by FIGS. 5A through 5E.
  • certain steps may be automated by a control system based on sensor feedback or conditions detected by sensors or other features of the control system, and may be performed in part by a controller, logic board or circuit, or other processor of the control system.
  • processor may be implemented as an independent or standalone processor and, for example, in some implementations may be implemented as one or several processors of a surgical system that is in electronic communication with some or all of the components of the fluid delivery system, and that is capable receiving and providing control signals, sensor signals, and other signals to such components.
  • the one or more processors may be configured to provide control signals to control the operation of the suction pump 136 and inflation pump 134, such that those devices may be activated by user input to a software application, or may be activated automatically by a software application in response to sensor signals or other feedback.
  • the one or more processors may be configured to receive signals from the sensor 160, to control the content rendered by the display 400, and to selectively activate the suction and inflation pump 142, such that those devices may be activated automatically based upon received sensor 160 signals.
  • the surgeon may position 330 the second medical device 300 at an initial position (e.g., approximately 1 cm from the GE junction of the stomach) and operate the second medical device 300 to perform a first clamp step.
  • an initial position e.g., approximately 1 cm from the GE junction of the stomach
  • the one or more processors may operate an inflation pump to automatically inflate the shaping portion 104 of the first medical device until a signal from a pressure sensor (e.g., within the balloon inflation channel) indicates that a predetermined pressure has been reached, at which time the one or more processors may cease operation of the inflation pump, and may provide visual or audible feedback via a display, light indicator, speaker, or other output device to indicate that the predetermined pressure has been reached.
  • a pressure sensor e.g., within the balloon inflation channel
  • the one or more processors may cease operation of the inflation pump, and may provide visual or audible feedback via a display, light indicator, speaker, or other output device to indicate that the predetermined pressure has been reached.
  • the inflation pump While the system remains in a balloon inflation enabled state (e.g., until a subsequent user input selecting deflation) the inflation pump may idle, and only activate in order to maintain inflation of the balloon to the preconfigured pressure.
  • the one or more processors may be configured to monitor the pressure of the balloon in real time
  • the one or more processors may operate an inflation pump to automatically inflate 334 the stomach until a signal from a pressure sensor (e.g., within the stomach inflation channel) indicates that a predetermined pressure has been reached, or until a preconfigured maximum inflation time has been reached, whichever occurs first, at which time the one or more processors may cease operation of the inflation pump, and may provide visual or audible feedback via a display, light indicator, speaker, or other output device to indicate that the predetermined pressure has been reached.
  • a pressure sensor e.g., within the stomach inflation channel
  • the inflation pump may idle, and only activate in order to maintain inflation of the stomach to the preconfigured pressure.
  • the maximum inflation time for the stomach may be configured based on a time threshold per inflation event and/or per procedure to ensure that excessive air does not escape into the small bowel during inflation, as this may impede visualization at the surgical site.
  • automatic maintenance of stomach inflation at the predetermined pressure may be disabled for a period of time.
  • the one or more processors may determine 335 whether a preconfigured pressure change threshold for the pressure within the balloon is exceeded based on feedback from a pressure sensor within the balloon channel.
  • the pressure change threshold may be configured to detect a change in pressure of the balloon that corresponds to the second medical device 300 being pulled into position snug against the shaping member 104.
  • the one or more processors may be configured to identify and distinguish such a pressure change based on immediate pressure, immediate change in pressure (e.g., between two measurements), or change in pressure over a period of time (e.g., over a plurality of measurements).
  • a rise in pressure over a period of time and of a magnitude that falls within pre-configured ranges that correspond to gradual inflation of the stomach may be detected as contact, while a rise in pressure that falls outside of such ranges (e.g., such as a sudden and substantial change as might result from an external force applied to the stomach, or a small change such as might result from a signal variance or other condition) may be disregarded.
  • the pressure change threshold may be statically configured, or may be dynamically configured at the time of the procedure, and for example may be configured based upon observed pressure measurements from the same or similar procedures.
  • the one or more processors are configured to provide 336 a position alert to indicate proper position of the second medical device 300, and to operate a suction pump to automatically deflate 338 the stomach.
  • the observable automatic deflation 338 of the stomach serves as the position alert 336. The surgeon may then perform 340 a second clamp step with the second medical device 300.
  • the one or more processors are configured to continue automatically applying 342 suction to the stomach to maintain it in a fully deflated state while the surgeon may position the antrum as has been described above and perform 344 a third clamp stage to fully close the second medical device 300.
  • the one or more processors may operate a suction pump to deflate 346 the balloon (e.g., either automatically in response to full close of the device, or based upon a subsequent user input).
  • the first medical device 100 may be configured to provide suction.
  • the first medical device 100 may include a lumen opening to the outside of the first medical device 100 (e.g., lumen 120).
  • One or more suction apertures may be distributed along the length of the catheter.
  • the lumen may extend through the first medical device 100, and suction openings may be provided at a distal end of the lumen.
  • the first medical device 100 or other component providing suction may include a suction control valve that may be used to regulate when and how suction may be applied.
  • Embodiments may incorporate the serial or simultaneous use of suction and inflation to create a desired sleeve geometry.
  • the shaping portion 104 may include an area in communication with the stomach lumen configured to allow for inflation or suction between two balloons 114.
  • the shaping portion 104 may include a first balloon 114a and a second balloon 114b separated by a section of the tube portion 102.
  • the shape of the first and second balloons 114a,b may be the same or may be different.
  • the first balloon 114a may have a tapered shape (e.g., conical frustum shape) and the second balloon 114b may have, for example, a disc shape.
  • the first balloon 114a When positioned in the stomach, the first balloon 114a may extend from the GE junction 18 to the IA 20, and the second balloon 1 14b may be adjacent the antrum 22.
  • the section of the tube portion 102 between the first and second balloons 114a, b may be in communication with the stomach lumen.
  • the section may include suction apertures 146, such as holes, mesh, or other porous features, that allow air to pass in and out of the tube portion 102.
  • the tube portion 102 may have multiple lumens including, in an embodiment, a lumen coupling the holes, mesh, or other porous features with an inflation and/or suction pump (e.g., lumen 120). Referring to FIG.
  • one or both of the balloons 114a, b may also include suction apertures 148 and be coupled to a suction pump. Additionally, the section of the tube portion 102 between the first and second balloons 114a, b may also be coupled to a pump capable of applying positive pressure in addition to applying suction. In an embodiment, as shown in FIG. 6C, a section of the tube portion 102 distal of the second balloon 1 14b may include suction apertures 150. The suction apertures 150 may be independently operable from the suction apertures 146. For example, suction may be applied through the suction apertures 150 while positive pressure is applied through the suction apertures 146 or vice versa.
  • suction may be applied to the section between the first and second balloons when the balloons are in a deflated state, an inflated state, or when the balloons are transitioning between those two states.
  • suction may be applied between the first and second balloons 114a,b to help bring tissue closer to the first and second balloons 114a,b while the stomach lumen is being inflated and the second medical device 300 is being urged by the balloon-like stomach to become snug against the first medical device 100.
  • suction may be applied between the first and second balloons 114a, b to help deflate the stomach lumen before the second medical device 300 has been clamped or the lumen of the desired sleeve after the second medical device 300 has been clamped.
  • an additional catheter or other tube separate from the first medical device 100 is in fluid communication with the stomach lumen.
  • the catheter may provide positive pressure in the stomach lumen.
  • the catheter may also be configured to provide a suction force.
  • a needle may be inserted into the portion of the stomach to be removed during the gastrectomy procedure ("remnant portion"), where the needle is coupled to a pump capable of suction and/or inflation.
  • a grasper may be used to control the position of the stomach, for example, when a catheter or needle is inserted other than through the esophagus.
  • the first medical device 100 may include an overtube 152.
  • the overtube 152 can be more rigid than the shaping portion 104 and may be slid over the exterior of the shaping portion 104.
  • the overtube 152 may be used during insertion of the first medical device 100 into the stomach.
  • the overtube 152 is flexible enough to act as an introducer sheath.
  • the overtube 152 may optionally include peel-away handles 154 for the surgeon or other user to pull.
  • the handles 154 can be small finger grips, such as those commonly used on transcatheter cardiovascular devices, which allow the overtube 152 to be removed by pulling it back.
  • the peel-away function can allow the overtube 152 to slide back over a catheter bifurcation hub. If the overtube 152 is still positioned on the shaping portion 104 when it is inflated, the overtube 152 can alter the shape and pressure distribution of the shaping portion 104.
  • the overtube 152 may be used to ensure that the stapler is positioned about 1 cm from the GE junction 18 at the top of the resection line.
  • the first medical device 100 is configured to allow another device, such as a gastroscope 156, to pass through the first medical device 100.
  • the gastroscope 156 may extend through the lumen 120 of the first medical device 100 and out of the distal aperture 122 (FIG. 8A).
  • the first medical device 100 may include a channel 158 extending through a portion or the entirety of the length through which the gastroscope 156 may pass (FIG. 8B). The channel 158 may be coextensive with the lumen 120.
  • the first medical device 100 may include a separate lumen opening to the stomach lumen to control the pressure therein.
  • the system may include one or more sensors 160, such as pressure sensors, flow sensors, volume sensors, etc.
  • the sensors may be digital or mechanical.
  • a sensor may be an in-line sensor.
  • a suitable example pressure sensor is a 0-5psi OmegaTM digital pressure transducer (PX26-005GV).
  • the one or more sensors may include a display or may be in communication with a display 400, monitor, or control system, such as one discussed below.
  • mechanical sensors may use a spring or column of fluid to display the measured pressure (e.g., stomach pressure, back-pressure on the inflated shaping portion, suction, etc.).
  • the display may include an indicator to identify whether the measured pressure is low, high, or in an acceptable range.
  • a color-coded range can be used to correlate the measured pressure or volume in the stomach lumen to the desired tension of the stomach tissue.
  • any sensor(s) can communicate data via a wireless or wired connection one or more of the first medical device, the second medical device, or a remote device, such as a display.
  • information collected by the sensor(s) can be transmitted using wireless connections (e.g., Bluetooth, Wi-Fi, a cellular network, a satellite, etc.) or wired connections (e.g., cable, copper or fiber optics, etc.).
  • the system may be configured to control or detect a volume of inflation.
  • the system may include a monitor or control system for the monitoring and metering of the fluid to be delivered.
  • the volume of inflation detected and/or controlled may be the volume of the stomach lumen and/or the volume of the shaping portion.
  • the volume of the resultant sleeve may also be controlled.
  • the fluid source may be a syringe or other container with a known volume of fluid. For example, a 60mL or 100mL syringe may be used as a fluid source for the inflation of the stomach lumen.
  • the fluid source may be configured to provide an indication of the volume of fluid used to inflate the stomach lumen (e.g., measurements on a syringe or container).
  • the pump may be used to apply discrete volumes of fluid.
  • a hand pump for example, may have a known volume of fluid per application (e.g., squeeze).
  • an electric pump may have a known flow rate, and the system may be configured to detect the volume used based on the time the pump was activated.
  • a flow meter or flow sensor may be used to measure the flow of fluid into the stomach lumen.
  • the system may be configured to measure a pressure drop (e.g., with a pressure sensor) in the compressed fluid container to determine the volume of fluid used.
  • the system may also include, in example embodiments, an integrated valve that discontinues fluid flow when a predetermined volume in the stomach lumen is reached.
  • the integrated valve may be in communication with the controls or a sensor.
  • the system will include controls 402 for controlling the inflation and/or suction.
  • the first medical device 100, the second medical device 300, or a remote device may include controls in wireless or wired communication with the pump system.
  • the controls 402 can include a monitor or control system for the monitoring and metering of the fluid to be delivered as discussed above.
  • the second medical device 300 includes switches or buttons to control the inflation and/or suction of the balloon and inflation and/or suction inflation of the stomach lumen.
  • the controls 402 may include, for example, a power button or a "zero" or tare button.
  • the system may include a display 400.
  • the display 400 may be configured to show data, such as pressure data relating to the shaping portion and/or the stomach lumen.
  • the display 400 may be on one of the first medical device 100, the second medical device 300, or a separate display device.
  • the display device may include controls (e.g., controls 402) in wireless or wired communication with the inflation/suction system.
  • the display 400 may also be configured to show data history (e.g., in a graph updating in real-time) or recent changes in the data.
  • the display device may have a hook or a handle.
  • the display device may be hangable from an IV pole.
  • the display in some embodiments, may be in communication with a camera and be configured to show the video feed (e.g., from gastroscope 156).
  • the display device may be a remote device such as a mobile phone or computer.
  • the display 400 may include an indicator 404 to identify whether the measured pressure is low, high, or in an acceptable range. For example, a color-coded range can be used to correlate the measured pressure in the stomach lumen to the desired tension of the stomach tissue.
  • the display 400 may be configured to provide a signal, such as an audio or visual signal. A signal may be provided for various reasons, such as when the tissue tension is at a predetermined value, if there is too much tension, if there is too little tension, etc.
  • the relative maximum pressure of the shaping portion and the stomach lumen may be controlled based on the materials, dimensions, resistance, and fluid flow rates of the system.
  • the system can include one or more relief valves 162.
  • the first medical device 100 may include a first relief valve, such as a pop-off or check valve, set at a predetermined maximum pressure of the shaping portion 104.
  • the first relief valve may be in fluid communication with the lumen of the stomach as well as the lumen of the shaping portion 104.
  • the first relief valve may open into a lumen that opens into the stomach lumen. The first relief valve may vent the excess fluid into the lumen of the stomach.
  • the shaping portion 104 will fill with fluid until the maximum pressure is reached causing additional fluid to vent into the stomach lumen, thus increasing the pressure in the stomach lumen. Due to the first relief valve, the shaping portion 104 maintains a higher pressure than that in the stomach lumen.
  • the first medical device 100 or other component providing inflation may include a relief valve to prevent over-pressurization of the stomach lumen.
  • the second relief valve may be set to a predetermined maximum pressure of the stomach.
  • the predetermined maximum pressure of the stomach lumen is lower than the predetermined maximum pressure of the shaping portion.
  • a suitable example of a relief valve is a flutter valve (a.k.a. duckbill or Heimlich valve).
  • a relief valve may provide an indication (e.g., audible or visible) that the predetermined pressure has been reached (e.g., maximum balloon pressure or maximum pressure in the stomach lumen).
  • the second medical device may be partially clamped on a bottom part of the stomach (i.e., distal relative to the first medical device, proximal relative to the second medical device).
  • the proximal end of the second medical device may be clamped from the bottom end of the stomach extending upwardly along a portion of the antrum, while the distal end of the second medical device remains unclamped.
  • the shaping portion of the first medical device may be inflated or expanded before the first, partial clamp is made.
  • the location of the partial clamp may be determined based on the desired size of the antrum in the resulting sleeve.
  • the second medical device may be repositioned or angled such that the distal end of the second medical device is near the GE junction.
  • the stomach lumen may be inflated as described above.
  • the second medical device may be urged against the first medical device, and the remainder of the second medical device may then be clamped. Partially clamping the proximal end of the second medical device before inflating the stomach lumen allows for precise control of the size of the antrum in the resulting sleeve.
  • a bottom portion of the stomach may be stapled along the resection line before the stomach lumen is inflated.
  • the bottom end of the stomach extending upwardly along a portion of the antrum may be stapled.
  • the location of the resection line and stapling may be determined based on the desired size of the antrum in the resulting sleeve.
  • the bottom portion of the stomach may be stapled using the second medical device or a separate stapler.
  • the shaping portion of the first medical device may be inflated or expanded before the initial stapling.
  • the second medical device may be positioned or angled such that the distal end of the second medical device is near the GE junction.
  • the stomach lumen may be inflated as described above.
  • the second medical device may be urged against the first medical device, and the remainder of the second medical device may then be clamped.
  • the remainder of the stomach along the resection line may be stapled. Partially stapling the bottom end of the stomach before inflating the stomach lumen allows for precise control of the size of the antrum in the resulting sleeve. Due to the partial stapling at the bottom of the stomach, the resection line may not be a straight line.
  • a connector 406 may be coupled to two segments of the stomach to pull the antrum through the second medical device 300.
  • a connector 406 may be coupled at one end 408 to a first section of the stomach (e.g., the fundus 24 or body 26 adjacent or along the greater curvature 28) and at the other end 410 to the antrum 22 (e.g., adjacent or along the greater curvature 28).
  • a first section of the stomach e.g., the fundus 24 or body 26 adjacent or along the greater curvature 28
  • the antrum 22 e.g., adjacent or along the greater curvature 28
  • the connector will pull the antrum tissue along with the first section resulting in a smaller portion of the antrum remaining in the desired sleeve (e.g., to the right of the second medical device).
  • the connector can be rigid (e.g., a suture) or a semi-compliant material.
  • the connector 406 can be an elastomeric material or spring element capable of being anchored to the stomach (e.g., with surgical clips or other mechanical means) either integrated into the connector 406 or applied directly to the connector 406.
  • the connector 406 can be implantable or removable; it will be removed with the remnant portion of the stomach.
  • the distal end 306 of the second medical device 300 may be initially clamped from the top end of the stomach (e.g., approximately 1cm from the GE junction) extending downwardly along a portion of the stomach, while the proximal end 308 of the second medical device 300 remains unclamped.
  • the top end of the stomach may be clamped while the shaping portion 104 of the first medical device 100 is inflated or expanded and while the stomach lumen is inflated.
  • the pressure in the stomach lumen may be increased after the top end of the stomach is clamped.
  • the positive pressure in the stomach lumen may be in a range of about 1 mmHg to about 5mmHg when the top of the stomach is partially clamped, and the pressure may be increased to be in a range of about 20mmHg to about 25mmHg.
  • the pressure after the top end of the stomach is clamped may be increased to about 20mmHg or about 25mmHg.
  • the direction of expansion of the stomach will be affected by the partial clamp at the top of the stomach.
  • the antrum 22 will expand further due to the increased pressure causing more of the tissue to move through the second medical device 300 to the remnant side.
  • the second medical device 300 may be fully clamped. Partially clamping the distal end 306 of the second medical device 300 before inflating the stomach lumen further allows for precise control of the size of the antrum 22 in the resulting sleeve.
  • the proximal end 112 of the intragastric section 110 of the first medical device 100 may be configured to anchor the tissue at the top end of the stomach.
  • the first medical device 100 may be configured to provide suction at or near the proximal end 112. The suction may allow the first medical device 100 to hold the adjacent tissue in place. While the shaping portion 104 of the first medical device 100 is inflated or expanded and while the stomach lumen is inflated, the top end of the stomach may be suctioned to the proximal end 112 of the first medical device 100.
  • the negative pressure used to hold the stomach tissue in place may be in a range of about 20mmHg to about 200mmHg, in a range of about 115mmHg to about 135mmHg, or about 125mmHg.
  • the pressure in the stomach lumen may be increased after the top end of the stomach is anchored in place.
  • the positive pressure in the stomach lumen may be in a range of about 1 mmHg to about 5mmHg when the top of the stomach is suctioned, and the pressure may be increased to be in a range of about 20mmHg to about 25mmHg.
  • the pressure after the top end of the stomach is suctioned in place may be increased to about 20mm Hg or about 25mmHg.
  • the direction of expansion of the stomach will be affected by the suction at the top of the stomach.
  • the antrum 22 will expand further due to the increased pressure causing more of the tissue to move through the jaws 302, 304 of the second medical device 300 to the remnant side.
  • the second medical device 300 may be clamped, and the suction at the proximal end 112 of the first medical device 100 may be discontinued.
  • Anchoring the top end of the stomach before inflating the stomach lumen further allows for precise control of the size of the antrum 22 in the resulting sleeve. Examples of suction being applied by the first medical device 100 are described herein (e.g., FIGS. 6B, 6C, and 10).
  • the stomach may be overinflated such that a portion of the first medical device 100 moves partially through the jaws 302, 304 of the second medical device 300 before the second medical device 300 is clamped.
  • the second medical device 300 is in an open position, and the stomach lumen is inflated.
  • the pressure in the stomach lumen is increased until the tissue along the lesser curvature 16 of the stomach is tensioned to the point where it pushes at least a portion of the first medical device 100 through the open jaws 302, 304 of the second medical device 300.
  • a middle portion of the intragastric section 110 of the first medical device 100 may move through the jaws 302, 304.
  • the pressure in the stomach lumen is then reduced, allowing the first medical device 100 to return to the right (or the sleeve side) of the second medical device 300.
  • the shaping portion 104 of the first medical device 100 is then inflated or expanded.
  • the pressure in the stomach lumen is increased to urge the second medical device 300 against the first medical device 100, as described above, and then clamped.
  • tissue from the antrum 22 also moves through the jaws 302, 304 to the remnant side. This process may result in more antrum tissue in the remnant side than would otherwise exist.
  • the first medical device 100 may be configured to anchor a section of the antrum 22 to a distal portion of the first medical device 100. Afterwards, the distal portion of the first medical device 100 may be moved towards the second medical device 300.
  • the first medical device 100 may be configured to apply suction, for example, at a distal portion thereof.
  • An example embodiment is described above in reference to FIG. 6B.
  • the first medical device 100 may include mesh 164 (or other suction apertures) coupled by a lumen 166 to a pump. In an embodiment, the mesh 164 may be about 30mm to about 70mm from the distal tip.
  • the mesh 164 may begin, in some embodiments, at the distal end 108 of the tube portion 102. In an embodiment, the mesh 164 may extend about 21cm from the distal end 108. The mesh 164 may be continuous or segmented.
  • the pump may apply a negative pressure through the lumen 166 causing tissue adjacent to the mesh 164 to be suctioned against the mesh 164.
  • the negative pressure used to hold the stomach tissue in place may be in a range of about 20mm Hg to about 200mmHg, in a range of about 115mmHg to about 135mmHg, or about 125mmHg.
  • the suction may anchorthe tissue, such as antrum tissue, to the distal portion of the first medical device 100. As described further below, the distal portion of the first medical device 100 may be moved towards the second medical device 300 before the second medical device 300 is clamped, which allows for more precise control of the size and shape of the resulting sleeve.
  • the first medical device 100 may include an articulating tip 168 in various embodiments.
  • the first medical device 100 may include an elongate arm 170 including a plurality of ribs 172.
  • the ribs 172 define a plurality of spaces 174 that allow the elongate arm 170 to bend in at least one direction.
  • the first medical device 100 also includes a tensioning element 176 coupled to a distal portion of the elongate arm 170.
  • the tensioning element 176 may be flexible, such as a wire, thread, rod, etc. In an embodiment, the tensioning element 176 extends through the ribs 172, as well as the spaces 174 between the ribs 172.
  • the elongate arm 170 and/or the tensioning element 176 may extend through a conduit 178 that extends through the tube portion 102.
  • the proximal end of the tensioning element 176 may extend out of the tube portion 102 to be manipulated by a surgeon.
  • the distal end of the tensioning element 176 may move between a first position and a second position.
  • the distal end of the tensioning element 176 may be pulled proximally from the first position to the second position, which causes the ribs 172 to move closer to one another (i.e., the spaces 174 between the ribs 172 become smaller or disappear).
  • the second position of the articulating tip 168 is shown in dashed line in FIG. 10.
  • a shaping portion 104 is not shown in FIG. 10, although it is contemplated that the mesh 164 may be distal of the shaping portion 104 or may extend over the shaping portion 104.
  • the mesh 164 may cover at least a portion of a balloon 114 and may be flexible such that it expands when the balloon 114 is inflated.
  • the first medical device 100 may also include a lumen (e.g., lumen 120) that is configured to control inflation of the stomach lumen. In use, the first medical device 100 may be inserted into the stomach lumen.
  • the articulating tip 168 may be tensioned such that the articulating tip 168 bends towards the lesser curvature 16 of the stomach.
  • Suction may be applied to the mesh 164 to anchor antrum tissue to the articulating tip 168.
  • Suction may be applied before or after the shaping portion 104 is inflated or expanded. Inflating or expanding the shaping portion 104 after the tissue has been anchored may help move the antrum tissue further due to the changing shape of the shaping portion 104.
  • the articulating tip 168 may then be released to its first position. As the articulating tip 168 moves away from the lesser curvature 16 (i.e., towards the second medical device 300), the anchored tissue of the antrum 22 moves at the same time.
  • the stomach lumen may then be inflated to urge the second medical device 300 against the first medical device 100, and the second medical device 100 may be clamped. As described above, anchoring the antrum tissue and moving it towards the second medical device 300 allows for more precise control of the size of the antrum in the resulting sleeve.
  • the shaping portion of the first medical device may be a non-compliant balloon material (e.g., nylon, polyester, etc.) or a semi-compliant balloon material (e.g., Pebax®, high-durometer polyurethane, etc.).
  • a non-compliant balloon material e.g., nylon, polyester, etc.
  • a semi-compliant balloon material e.g., Pebax®, high-durometer polyurethane, etc.
  • the initial low or medium pressure may be enough pressure to demonstrate the correct sleeve size but not enough to straighten out the balloon 114.
  • the balloon may be inflated to a high pressure, which may straighten the balloon 114 and moves the antrum tissue further through the jaws 302, 402.
  • a non-compliant or semi-compliant balloon may be used, for example, in combination with an articulating tip 168 as described above.
  • an additional device may be used to straighten the first medical device after tissue has been anchored to it.
  • the first medical device 100 may have a naturally curved distal portion, and a stylet 412 may be inserted through the first medical device 100 to straighten or move the curved portion towards the second medical device 300.
  • the first medical device 100 may be inserted into the stomach lumen where the distal portion curves toward the lesser curvature 16 of the stomach.
  • the tissue such as antrum tissue, may be anchored to the distal portion (e.g., using suction as described above).
  • a stylet 412 or other rigid component may be inserted through the first medical device 100. As the stylet 412 enters the distal portion of the first medical device 100, the distal portion will straighten out or move towards the second medical device 300 (as shown in FIG. 11 B). As described above, anchoring the antrum tissue and moving it towards the second medical device 300 allows for more precise control of the size of the antrum 22 in the resulting sleeve.
  • an anchor 180 may be positioned on a distal portion of the first medical device 100.
  • the anchor 180 may be configured to "grab" adjacent tissue (e.g., the mucosa).
  • the anchor 180 may include, without limitation, hooks (e.g., similar to those used in hook-and-loop fasteners), a barb, a clip, a magnet, a suture, or a combination thereof.
  • An overtube or introducer sheath may be used when inserting a first medical device 100 including an anchor 180, which can reduce the chance of unintentionally anchoring tissue before the first medical device is in proper position 100.
  • the first medical device 100 may include a perforated sheath 182.
  • the perforated sheath 182 may extend from the distal end 108 of the first medical device 100 proximally along a length of the first medical device 100.
  • Suction apertures 184 e.g., holes, or other openings, e.g., mesh
  • the perforations can extend between about 30mm to about 70mm from the distal end or about 21 cm from the distal end.
  • the perforations may begin, in some embodiments, at the distal end of the perforated sheath 182. In an embodiment, the perforations may extend about 21cm from the distal end of the perforated sheath 182.
  • the perforated sheath 182 may be continuous or segmented.
  • the suction apertures 184 are coupled to a pump.
  • the perforated sheath 182 may extend over the shaping portion 104 or a portion thereof. At least a portion of the perforated sheath 182 may be flexible or expandable such that, when the shaping portion 104 is inflated or expanded, the adjacent portions of the perforated sheath 182 also expand (FIG. 12B). In an embodiment, as shown in FIG.
  • the perforated sheath 182 may include grooves 186 (e.g., channels or other lumens) coupling the suction apertures 184 to the pump.
  • the grooves 186 may be rigid to maintain the connection between the suction apertures 184 and the pump when the perforated sheath 182 is expanded by the shaping portion 104. In other words, the expansion of the shaping portion 104 does not cause the grooves 186 to collapse thereby cutting off the suction.
  • the distal portion of the first medical device 100 may be moved towards the second medical device.
  • the first medical device may include an articulating tip 168 or a stylet 412 may be used, as discussed above.
  • An overtube, such as overtube 152 may be positioned over the perforated sheath 182.
  • an overtube may be used as an introducer sheath when inserting or removing the first medical device 100 from the stomach lumen.
  • a temporary soluble adhesive coating may be included on a portion of the first medical device (e.g., on a portion of a balloon that, when expanded, is adjacent the antrum).
  • a temporary soluble adhesive may be exuded through pores on the first medical device.
  • the first medical device 100 may include an inflatable or expandable portion 188 in addition to and separate from the shaping portion 104 (not shown).
  • the inflatable or expandable portion 188 may be extended through the pyloric sphincter 30 and inflated or expanded such that it cannot be easily removed through the pyloric sphincter 30. As the distal portion of the first medical device 100 is moved towards the second medical device 300, the inflatable or expandable portion 188 pulls the pyloric sphincter 30 and the surrounding tissue in the same direction. It will be appreciated that any techniques described herein to anchor tissue to the first medical device may be used with techniques described herein to move a portion of the first medical device toward the second medical device. It will also be appreciated that other techniques may be used to perform the anchoring or the movement.
  • inflation of the stomach may be at least partially controlled from the desired remnant portion of the stomach.
  • a needle may be inserted in the stomach lumen on the opposite side of the second medical device 300 from the first medical device 100 (e.g., through the fundus 24 or body 26 near the greater curvature 28) to apply inflation or suction.
  • an inflatable or expandable component such as a balloon 414
  • the balloon 414 may be inserted through a needle 416 or catheter.
  • the balloon 414 may be inflated to urge the second medical device 300 towards the first medical device 100.
  • the shape of the balloon 414 may be determined based on the shape of the desired sleeve.
  • the portion of the balloon 414 adjacent the antrum 22 may be shaped to move a desired portion of the antrum tissue through the jaws 302, 304 of the second medical device 300.
  • Graspers 418 may be used to control the stomach to prevent unintentional injury (e.g., unintentionally pulling out the needle 416 before the balloon 414 is fully deflated).
  • the system may use dynamic feedback.
  • the system may be configured, in some embodiments, to automatically control pressurization of the stomach lumen based on the feedback.
  • the system may use dynamic feedback to determine when to clamp the second medical device.
  • the second medical device may be clamped manually or automatically based on the feedback.
  • the shaping portion 104 can include one or more segments 104a.
  • Each segment 104a of the shaping portion 104 may be coupled with a fluid source, for example, through separate lumens (e.g., lumen 128).
  • Each segment 104a may also be in communication with one or more sensors 160 (e.g., shown in FIGS.
  • each segment may be independently filled with a fluid under pressure.
  • a catheter in communication with the stomach lumen e.g., part of the first medical device 100 or a separate component as described above
  • Fluid is introduced to the stomach lumen thus increasing the pressure and tension according to the Law of Laplace, as described above.
  • each segment 104a will press against each segment 104a.
  • the backpressure at each segment 104a will vary based upon the magnitude of the tissue tension as a function of the inflation pressure and as the second medical device is clamped.
  • Each segment 104a may have a predetermined backpressure value that indicates that the desired tissue tension has been achieved for the respective segment 104a and related area of the sleeve. Once the predetermined pressure is reached, the second medical device 300 is closed for that segment 104a of the desired sleeve.
  • the stomach continues to be tensioned with positive pressure in the lumen until the predetermined pressure of the next shaping portion segment 104a is reached (again indicating the desired tissue tension has been achieved in that segment 104a of the sleeve).
  • that portion of the second medical device 300 is closed. This is continued until the entire second medical device 300 is closed, thus ensuring the entire sleeve was formed to have the desired tension lines.
  • Having multiple segments 104a allows for different shapes for different portions of stomach (e.g., body 26, IA 20, antrum 22).
  • the pressure of the shaping portion 104 or individual segments 104a may be 'zeroed' after inflating the shaping portion and before inflating the stomach lumen. This may all the surgeon or other user to easily visualize small changes in backpressure, which may be small relative to the overall pressure keeping the balloon inflated.
  • the shaping portion 104 may be segmented along the length thereof.
  • Each segment 104a may be coupled to a pump and one or more sensors, as discussed above. Based on the magnitude of the backpressure each segment 104a is experiencing, the system and/or the surgeon may be able to determine the position of the surrounding tissue before clamping the second medical device.
  • the segments 104a adjacent the lesser curvature 16 experiencing a relatively high backpressure may indicate that the lesser curvature 16 of the stomach is in the desired position relative to the first medical device 100 (FIG. 16B).
  • all of the segments 104a experiencing a relatively high backpressure may be an indication that the tissue surrounding the first medical device 100 is in the desired position and the second medical device 300 may be clamped (FIG. 16C).
  • the system may use dynamic feedback to reach the desired pressure in both the shaping portion and the stomach lumen.
  • the system may adjust the inflation (e.g., add more pressure or use suction to reduce pressure) of the stomach lumen and/or the shaping portion based on feedback from the first medical device.
  • the pressure may be adjusted manually or automatically based on the feedback.
  • the first medical device could include one or more segments coupled to one or more sensors, such as with the configurations in FIGS. 15-16C.
  • the measured backpressure at the one or more segments may be used in determining whether to increase, maintain, or reduce pressure in the stomach lumen.
  • inflation and suction may be alternated to position portions of the stomach tissue relative to the second medical device as desired.
  • the backpressure on the shaping portion may slightly increase after the second medical device is clamped.
  • feedback other than backpressure on the first medical device may be used to determine when to clamp the second medical device.
  • the first medical device may be configured to determine whether the tissue surrounding the first medical device is properly tensioned.
  • the first medical device may be configured to measure suction in zones along the length of the first medical device.
  • the shaping portion for example, can include more than one sets of suction apertures (or other openings as discussed above).
  • the suctions apertures may be arranged in zones or separate segments. For example, as shown in FIGS. 17A and 17B, four zones of suction apertures 187 are arranged around a diameter of the tube portion 102 of the first medical device 100.
  • the suction apertures 187 may extend along the first medical device 100 for about the length of the stomach (e.g., about 21 cm). Each of the suction apertures 187 in the same zone are collectively coupled to a pump (e.g., a single pump or individual pumps) and a sensor. For example, a lumen 189 may couple each suction aperture 187 in a respective zone with the pump.
  • the shaping portion 104 may define channels for each of the suction apertures 187 such that the shaping portion 104 does not interfere with suction from the tube portion 102. As the stomach is inflated and the second medical device 300 is being urged against the first medical device 100, suction may be applied to each zone.
  • An example negative pressure may be in a range of about 20mmHg to about 200mmHg, in a range of about 115mmHg to about 135mmHg, or about 125mmHg.
  • the system may be configured to determine when the suction apertures 187 in each zone become occluded (e.g., by adjacent tissue). The suction may be discontinued in a zone where the suction apertures 187 have become occluded. Based on the number of zones that are occluded or which specific zones are occluded, the system and/or the surgeon may be able to determine the position of the surrounding tissue before clamping the second medical device. For example, two of four zones being occluded may indicate that the lesser curvature 16 of the stomach is grounded to the first medical device. Additionally, all of the zones being occluded may be an indication that the tissue surrounding the first medical device 100 is in the desired position and the second medical device 300 may be clamped.
  • the first medical device may include 8 suction zones.
  • the shaping portion 104 of the first medical device 100 may include a separate lumen 190 for each zone.
  • the lumens 190 may each extend from a closed proximal end 192 to an open distal end 194 and be in communication with a plurality of suction apertures 196.
  • the tube portion 102 of the first medical device 100 may include tube openings 198, each of which correspond to a separate lumen 190.
  • the tube openings 198 may be collectively coupled to a pump.
  • the tube openings 198 are positioned on a sidewall 200 of the tube portion 102 adjacent the distal end 108.
  • Each tube opening 198 and corresponding lumen 190 are in fluid communication with each other.
  • the shaping portion 104 may include a manifold cap 202 that couples each tube opening 198 to the corresponding lumen 190.
  • the manifold cap 202 may be segmented, and the number of segments may correspond to the number of suction zones.
  • the manifold cap 202 may include an inner wall 204 defining a channel 206 sized to receive the distal end 108 of the tube portion 102.
  • the inner wall 204 also defines apertures 207 configured to align with the tube openings 198 when the tube portion 102 extends into the channel 206.
  • each chamber 210 fluidly couples each aperture 207 with a corresponding open distal end 194 of a lumen 190.
  • the dividers 208 prevent or substantially prevent airflow between each chamber 210.
  • one source of suction is coupled to multiple independent zones.
  • the manifold cap 202 may also include an outlet 212 at its distal end. The outlet 212 may allow the lumen 120 in the tube portion 102 to be in communication with the stomach lumen (e.g., to control the pressure in the stomach lumen).
  • the zones of suction may be used by the surgeon or system to determine the position of tissue surrounding the first medical device 100 and/or when to clamp the second medical device 300.
  • the first medical device 100 may include suction lumens 214 positioned on an exterior of the shaping portion 104.
  • Each suction lumen 214 may include one or more suction apertures (not shown for clarity purposes).
  • the suction lumens 214 may each be coupled to a pump.
  • the system may be configured to measure the suction applied through each lumen 214.
  • each lumen 214 may be coupled to a sensor.
  • the suction lumens 214 are positioned longitudinally around a diameter of the shaping portion 104.
  • the suction lumens 214 may be flexible to allow for expansion when the shaping portion 104 is inflated or expanded.
  • the suction lumens 214 may be coupled to the shaping portion 104 or held in position on the shaping portion 104 by, for example, an outer elastic sheath 216.
  • the elastic sheath 216 is porous or otherwise perforated to allow suction from the suction lumens 214 through the elastic sheath 216.
  • the system may be configured to determine when the suction apertures in each lumen 214 become occluded (e.g., by adjacent tissue), which can be used to inform the system or the surgeon about the current state of the procedure or whether it is time to clamp the second medical device.
  • FIGS. 3, 4A, and 4B each show and describe fluid delivery systems, it should be understood that additional variations on fluid delivery systems exist and will be apparent to those of ordinary skill in the art in view of the teachings herein.
  • FIGS. 20A and 20B depict a controller 500 for a fluid delivery system.
  • the controller 500 includes a suction coupling 504 and an inflation coupling 502 that are each configured to attach to a tube, line, hose, or other channel that is in fluid communication with a source of suction or source of inflation.
  • the controller 500 also includes a stomach coupling 520 and a balloon coupling 522 that are similarly configured to attach to a tube, line, hose, or other channel that is in fluid communication with a feature of a medical instrument used to inflate and deflate the stomach (e.g., such as the distal aperture 122 of the first medical device 100) or an inflatable feature of a medical instrument (e.g., such as the shaping portion 104 of the first medical device 100, which includes inflatable balloons 114), respectively.
  • a medical instrument used to inflate and deflate the stomach e.g., such as the distal aperture 122 of the first medical device 100
  • an inflatable feature of a medical instrument e.g., such as the shaping portion 104 of the first medical device 100, which includes inflatable balloons 114
  • the controller 500 may be coupled to the suction pump 136 and the inflation pump 134 at the suction coupling 504 and inflation coupling 502 respectively, and may be coupled to the multi-lumen catheter 102 at the stomach coupling 520 and balloon coupling 522. Coupled to a fluid delivery system, implementations of the controller 500 may provide a simplified control device and interface for users that may be disposed of after one or several procedures. Implementations of the controller 500 are also advantageous in that the controller 500 may be coupled to the fluid deliver system in-line, and so may be supported by the incoming and outgoing channels to which it is coupled, or may be mounted to a nearby support structure.
  • the controller 500 As compared to more complex control systems, such as capital equipment that is fixed in place, or that is mobile and is wheeled to different procedure sites, the controller 500 has a substantially reduced form factor and footprint, and may be relocated and configured at a procedure site with substantially less effort.
  • the controller 500 is assembled from components that are entirely mechanical in function, while other implementations may contain electrical components of minimal complexity and usage requirements (e.g., pressure sensors or other sensors such as those described herein, lighted visual indicators) such that the controller 500 may be powered by a battery.
  • the controller 500 is shown with a rectangular cuboid housing or body, though it should be understood that the controller 500 may also be implemented with a housing of varying size and shape (e.g., cylindrical, oblong, cuboid, etc.), and such housing may include additional features such as mechanical mounting points (e.g., hooks, clamps, or other mechanical grips usable to mount the controller 500 to another structure at the procedure site) or tube mounting points (e.g., the housing of the controller 500 may include one or more tube fixtures that each receive a slack portion of a tube coupled to the controller 500 and isolate movement of that tube, such as to prevent accidental decoupling of the controller 500 from the fluid delivery system).
  • mechanical mounting points e.g., hooks, clamps, or other mechanical grips usable to mount the controller 500 to another structure at the procedure site
  • tube mounting points e.g., the housing of the controller 500 may include one or more tube fixtures that each receive a slack portion of a tube coupled to the controller 500 and
  • the controller 500 also includes a selector 506 that may be manually rotated into one of several positions to control the operation of the fluid delivery system, including for example an “off’ position in which no inflation is provided, a “stomach” position in which inflation is provided via the stomach coupling 520, and a “balloon” position in which inflation is provided via the balloon coupling 522.
  • a stomach suction button 508 may be actuated to provide suction via the stomach coupling 520
  • a balloon suction button 510 may be actuated to provide suction via the balloon coupling 522.
  • actuation of either suction button 508, 510 provides suction via the corresponding channel regardless of the position of the selector 506 (e.g., while the selector 506 is in the “stomach” position, the balloon suction button 510 may be actuated to deflate the balloon while inflation or deflation of the stomach is uninterrupted).
  • actuation of either suction button 508, 510 may interrupt inflation being provided via the corresponding channel or both channels (e.g., actuation of the balloon suction button 510 may interrupt inflation of the balloon, inflation of the stomach, or both).
  • the controller 500 also includes a stomach channel release valve opening 512 and a balloon channel release valve opening 514 that are each in fluid communication with a corresponding internal release valve.
  • Each release valve may be configured with static or selectable pressure limits related to pressure from inflation, deflation, or both, and such pressure limits may be the same or different for each channel (e.g., the pressure release valve for the balloon channel may be configured with a higher allowable pressure than the pressure release valve for the stomach channel).
  • the release valve When the release valve is triggered the valve will open to the atmosphere via the corresponding valve opening 512, 514 and pressure within the affected channel will be limited until the pressure is reduced and the release valve closes (e.g., automatically by a reduction of internal pressure in the case of a flexibly biased release valve, or manually where the release valve is not flexibly biased towards a closed state).
  • the controller 500 also includes a contact indicator 516 and an inflation indicator 518 that are configured to provide feedback to a user based upon the operation of a pressure sensor within the balloon channel.
  • Each indicator 516, 518 may be, for example, a lighted visual indicator such as a light emitting diode or other light source that illuminates based upon a signal from the pressure sensor, or may be an audible indicator such as a speaker or piezo element that provides an audible alert based upon a signal from the pressure sensor.
  • the inflation indicator 518 may be configured to activate when pressure within the balloon channel reaches a preconfigured pressure corresponding to full inflation of one or more balloons of a coupled medical device.
  • Implementations of the controller 500 may be powered by a replaceable or rechargeable battery, and may include a programmable logic controller, control board, processor and memory, or other logic circuitry, independent of or integrated with such sensors, that may be configured to receive and analyse sensor signals, and to activate the indicators 516, 518 based thereon.
  • the contact indicator 516 may be configured to activate when the one or more balloons are fully inflated and a subsequent increase in pressure within the balloon channel is detected. During performance of a procedure such as that illustrated in FIGS. 5A-5E, this subsequent increase in pressure within the balloon channel occurs when the second medical device 300 is positioned adjacent to and snug against the inflated shaping portion 104 during inflation of the stomach. As the inflated shaping portion 104 is contacted by the second medical device 300 a measurable increase in pressure within the balloon channel may be detected by the pressure sensor, and the contact indicator 516 may be activated in response to detection of such change.
  • the pressure sensor and/or contact indicator 516 may be configured to identify and distinguish such a pressure change based on immediate pressure, immediate change in pressure (e.g., between two measurements), or change in pressure over a period of time (e.g., over a plurality of measurements). In this manner, a rise in pressure over a period of time and of a magnitude that falls within pre-configured ranges that correspond to gradual inflation of the stomach may be detected as contact, while a rise in pressure that falls outside of such ranges (e.g., such as a sudden and substantial change as might result from an external force applied to the stomach, or a small change such as might result from a signal variance or other condition) may be disregarded.
  • Such pre-configured ranges may be statically configured for both indicators 516, 518, or may be dynamically configured at the time of the procedure, and for example may be configured based upon observed pressure measurements from the same or similar procedures.
  • the controller 500 may be implemented entirely with mechanical components, or with minimal non-mechanical components.
  • the selector 506 may be implemented as a stopcock or other rotatable valve that aligns internal fluid channels corresponding to the selected operation mode (e.g., both channels closed to inflation source, stomach channel open to inflation source, balloon channel open to inflation source).
  • each suction button 508, 510 may be implemented as mechanical push button valves that may be actuated to open and close the corresponding channel to the suction source, and in some implementations may also be configured to close one or more both channels to the inflation source when actuated, as has been described.
  • the contact indicator 516 and inflation indicator 518 may be omitted, and audible or visual observation of the balloon channel release valve opening 514 may be used as a substitute for visual or audible activation of the indicators 516, 518 (e.g., when the balloon initially reaches maximum inflation pressure may be observed being release via the valve opening 514, and subsequent increase in pressure resulting from positioning of the second medical device 300 against the balloon may be similarly observed).
  • controller 500 may include controls for mechanically or electronically adjusting the pressure limits of each channel pressure release valve, or for mechanically or electronically adjusting the activation threshold or range of one or both indicators 516, 518, or may include a user display component or graphical interface configured to display sensed pressure.
  • some implementations may include the addition of solenoid valve downstream of the balloon air input pressure relief valve to ensure air is not released from the balloon during mechanical retraction. The solenoid valve could be replaced by a purely mechanical spring loaded valve, that would require manual reset.
  • FIG. 20C provides additional examples related to the use of the controller 500 during a procedure and steps such as those illustrated and described above in the context of FIGS. 5A through 5F.
  • FIG. 5F describes a surgical system to provide automatic management of inflation, deflation, and other aspects of the procedure, some or all of which may not be supported by implementations of the controller 500.
  • the steps of FIG. 20C provide examples of use of the controller 500 to perform the procedure based at least in part upon sensorfeedback, particularly in relation to detecting when the second medical device 300 is positioned snug against the shaping portion 104.
  • the surgeon may position 530 the second medical device 300 at an initial position (e.g., approximately 1cm from the GE junction of the stomach) and operate the second medical device 300 to perform a first clamp step.
  • the shaping portion 104 of the first medical device 100 is then positioned, and the controller 500 is utilized to inflate 532 the shaping portion to a predetermined pressure (e.g., which may include operating the selector 506 to select the balloon channel, and then operating the selector 506 to turn inflation off in response to feedback from the inflation indicator 518).
  • the controller 500 is then utilized to inflate 534 the stomach to a predetermined pressure (e.g., which may include operating the selector 506 to select the stomach channel, and then operating the selector 506 to turn inflation off in response to feedback from the stomach channel release valve opening 512).
  • the controller 500 may then detect 536 a rise in balloon pressure corresponding to the second medical instrument 300 being positioned snugly against the shaping portion 104, and may provide an alert via the contact indicator 516.
  • the controller 500 may then be utilized to deflate 538 the stomach (e.g., which may include operating the stomach suction button 508 until the procedure is complete, or until the stomach is fully deflated, as may be indicated by feedback from the stomach channel release valve opening 512).
  • the surgeon may then perform 540 a second clamp step with the second medical device 300.
  • the surgeon may then continue applying suction to the stomach while positioning 542 the antrum as has been described above, and may perform 544 a third clamp stage to fully close the second medical device 300.
  • the surgeon may then use the controller 500 to deflate the balloon (e.g., which may include operating the balloon suction button 510 until the shaping portion 104 is fully deflated, as may be indicated by feedback from the balloon channel release valve opening 514).
  • implementations of the disclosed technology that include a surgical system including one or more processors may be configured to perform certain actions based upon user inputs to the system, which may include user inputs provided via a software application, or user inputs provided via actuation of buttons that transmit control signals or other information to the processors.
  • FIGS. 21 A through 21 C provide examples of control interfaces that may be implemented as a software user interface, a physical interface, or a combination thereof, and that may be configured to receive and provide user inputs to the one or more processors.
  • FIG. 21 A is a diagram illustrating a first control interface 730 for a fluid delivery system.
  • the first interface 730 includes a toggle power 712 control that may be selected to place the surgical system into a power-on or power-off state.
  • a toggle balloon inflation 714 control may be selected to place the surgical system into a balloon inflation enabled state or a balloon inflation disabled state, such as described in the context of FIG. 5F.
  • a toggle stomach inflate 716 control may be selected to place the surgical system into a stomach inflation enabled state or a stomach inflation disabled state, such as described in the context of FIG. 5F.
  • a sensitivity selector 718 may be selected in order to selectively adjust the sensitivity of the balloon channel pressure sensor in order to configure the predetermined pressure threshold for determining 335 that the second medical device 300 is properly positioned, as has been described in the context of FIG. 5F.
  • a stomach suction 720 control may be selected to manually apply suction to the stomach, and may be configured to override the toggle stomach inflate 716 control when pressed and/or to place the system in a stomach inflation disabled state.
  • FIG. 21 B is a diagram illustrating a second control interface 740 for a fluid delivery system.
  • the interface 740 includes the toggle power 712 control, toggle balloon inflation 714 control, toggle stomach inflate 716 control, sensitivity selector 718, and stomach suction 720 control, each having a similar or same configuration and effect as disclosed above in the context of FIG. 21A.
  • the interface 740 additionally includes a balloon target pressure selector 722 that may be selected to manually set a target inflation pressure at which the one or more processors will automatically operate an inflation pump to maintain pressure of the balloon.
  • the interface 740 also includes a stomach target pressure selector 724 that may be selected to manually set a target inflation pressure at which the one or more processors will automatically operate an inflation pump to maintain pressure of the stomach.
  • FIG. 21 C is a diagram illustrating a third control interface 750 for a fluid deliver system.
  • the control interface 750 includes the toggle power 712 control, toggle balloon inflation 714 control, toggle stomach inflate 716 control, and stomach suction 720 control, each having a similar or same configuration and effect as disclosed above in the context of FIG. 21A.
  • the control interface 750 advantageously provides a minimalist control interface, such as may be appropriate for a surgical system such as that described in the context of FIG. 5F that is configured to automate significant portions of the procedure.
  • the control interface 750 is also appropriate for a surgical system that preconfigured values for pressure ranges and thresholds that do not require adjustment by the surgeon during the procedure.
  • such ranges and thresholds may be calculated and preconfigured based upon factors such as the procedure type, the type and characteristics of the first and second medical device 100, 300, patient characteristics, and other characteristics.
  • such ranges may be statically configured based upon broadly acceptable ranges or parameters.
  • a statically preconfigured value for target balloon inflation pressure during the steps of FIGS. 5A through 5F is between about 30 mmHg and about 40 mmHg, with about 35 mmHg being advantageous. Inflation beyond that range tends to not properly retract and position the stomach, while inflation short of that range tends to allow the balloon to collapse, resulting in an unreliable sizing and positioning tool.
  • Versions of the devices described above may be actuated mechanically or electromechanically (e.g., using one or more electrical motors, solenoids, etc.).
  • actuation modes may be suitable as well including but not limited to pneumatic and/or hydraulic actuation, etc.
  • suitable ways in which such alternative forms of actuation may be provided in a device as described above will be apparent to those of ordinary skill in the art in view of the teachings herein.

Landscapes

  • Health & Medical Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Nursing (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Surgical Instruments (AREA)

Abstract

L'invention divulgue des modes de réalisation d'un appareil, d'un système et d'un procédé pour réaliser une gastrectomie à manchon. L'appareil peut comprendre une bougie destinée à être insérée à l'intérieur d'un estomac, la bougie ayant une extrémité de bougie proximale et une extrémité de bougie distale, une lumière de gonflage ayant une extrémité de lumière proximale et une extrémité de lumière distale, la lumière de gonflage s'étendant de l'extrémité de bougie proximale jusqu'à l'extrémité de bougie distale, un système de distribution de fluide accouplé à l'extrémité de lumière proximale, le système de distribution de fluide étant fonctionnellement conçu pour délivrer une pression positive dans une plage de pression positive prédéterminée dans l'estomac, et un moniteur couplé à l'extrémité de lumière proximale fonctionnellement conçu pour la surveillance d'une pression ou d'un volume à l'intérieur de l'estomac. La bougie peut être fonctionnellement conçue pour définir une ligne de résection pour la gastrectomie à manchon lorsque la plage de pressions positives prédéterminée est atteinte dans l'estomac.
PCT/US2023/020596 2022-05-06 2023-05-01 Systèmes et procédés de réalisation d'une chirurgie en utilisant la rétractation de tension de la loi de laplace pendant la chirurgie WO2023215239A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17/738,916 2022-05-06
US17/738,916 US20220257400A1 (en) 2019-11-04 2022-05-06 Systems and methods of performing surgery using laplace's law tension retraction during surgery

Publications (1)

Publication Number Publication Date
WO2023215239A1 true WO2023215239A1 (fr) 2023-11-09

Family

ID=88646881

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2023/020596 WO2023215239A1 (fr) 2022-05-06 2023-05-01 Systèmes et procédés de réalisation d'une chirurgie en utilisant la rétractation de tension de la loi de laplace pendant la chirurgie

Country Status (1)

Country Link
WO (1) WO2023215239A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030135091A1 (en) * 2002-01-11 2003-07-17 Masaaki Nakazawa Medical treatment method and apparatus
US20140114121A1 (en) * 2012-10-19 2014-04-24 Covidien Lp Devices and methods facilitating sleeve gastrectomy procedures
US20210128335A1 (en) * 2019-11-04 2021-05-06 Standard Bariatrics, Inc. Systems and methods of performing surgery using laplace's law tension retraction during surgery

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030135091A1 (en) * 2002-01-11 2003-07-17 Masaaki Nakazawa Medical treatment method and apparatus
US20140114121A1 (en) * 2012-10-19 2014-04-24 Covidien Lp Devices and methods facilitating sleeve gastrectomy procedures
US20210128335A1 (en) * 2019-11-04 2021-05-06 Standard Bariatrics, Inc. Systems and methods of performing surgery using laplace's law tension retraction during surgery

Similar Documents

Publication Publication Date Title
US11173060B2 (en) Systems and methods of performing surgery using Laplace's law tension retraction during surgery
US20210113358A1 (en) Systems and methods for performing bariatric surgery
US11253264B2 (en) System and method for low profile occlusion balloon catheter
US11511030B2 (en) Gastric sizing systems including instruments and methods of bariatric surgery
AU2010208117B2 (en) Cervical opening sealing devices
US11179178B2 (en) Vaginal positioner for uterine tamponade device and methods of using the same
CA2313113A1 (fr) Orifice d'acces pour laparoscopie, a soupape d'etancheite
US20220257400A1 (en) Systems and methods of performing surgery using laplace's law tension retraction during surgery
WO2023215239A1 (fr) Systèmes et procédés de réalisation d'une chirurgie en utilisant la rétractation de tension de la loi de laplace pendant la chirurgie
US20140249374A1 (en) Systems, devices and methods for creating an operative site within a patient
US20240173032A1 (en) Occlusion catheter system for partial occlusion or full occlusion
US20130184534A1 (en) Systems, devices and methods for creating an operative site within a patient

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23799887

Country of ref document: EP

Kind code of ref document: A1